Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:45 UTC |
---|
HMDB ID | HMDB0014837 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nicergoline |
---|
Description | Nicergoline is only found in individuals that have used or taken this drug. It is an ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease. [PubChem]Nicergoline acts by inhibiting the postsynaptic alpha(1)-adrenoceptors on vascular smooth muscle. This inhibits the vasoconstrictor effect of circulating and locally released catecholamines (epinephrine and norepinephrine), resulting in peripheral vasodilation. Therefore the mechanism of Nicergoline is to increase vascular circulation in the brain, thereby enhancing the transmission of nerve signals across the nerve fibres, which secrete acetylcholine as a neural transmitter. |
---|
Structure | [H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@]1(C[C@@H](COC(=O)C1=CC(Br)=CN=C1)CN2C)OC InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1 |
---|
Synonyms | Value | Source |
---|
Sermion | Kegg | Circo-maren | HMDB | Dexcel brand OF nicergoline | HMDB | Nicergolin atid | HMDB | Nicergolin lindo | HMDB | Nicergolin-neuraxpharm | HMDB | Nicergoline hexal brand | HMDB | Nicerium | HMDB | Nicotergoline | HMDB | Pfizer brand OF nicergoline | HMDB | Teva brand OF nicergoline | HMDB | CT Arzneimittel brand OF nicergoline | HMDB | Neuraxpharm brand OF nicergoline | HMDB | Ratiopharm brand OF nicergoline | HMDB | Circo maren | HMDB | Fisifax | HMDB | Hormosan brand OF nicergoline | HMDB | Nicergobeta | HMDB | Nicergolin neuraxpharm | HMDB | Nicergolin-ratiopharm | HMDB | Nicergoline pfizer brand | HMDB | Nicergoline teva brand | HMDB | Reig jofre brand OF nicergoline | HMDB | Aventis brand OF nicergoline | HMDB | F.I. 6714 | HMDB | Hexal brand OF nicergoline | HMDB | Lindopharm brand OF nicergoline | HMDB | Nicergolin-teva | HMDB | Betapharm brand OF nicergoline | HMDB | Kenfarma brand OF nicergoline | HMDB | Krewel brand OF nicergoline | HMDB | Nicergolin teva | HMDB | Nicergolin ratiopharm | HMDB | Nimergoline | HMDB | CT-Arzneimittel brand OF nicergoline | HMDB | Ergobel | HMDB | Nicergolin von CT | HMDB | Von CT, nicergolin | HMDB |
| Show more...
---|
Chemical Formula | C24H26BrN3O3 |
---|
Average Molecular Weight | 484.386 |
---|
Monoisotopic Molecular Weight | 483.11575436 |
---|
IUPAC Name | [(2S,4R,7R)-2-methoxy-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-4-yl]methyl 5-bromopyridine-3-carboxylate |
---|
Traditional Name | nicergoline |
---|
CAS Registry Number | 27848-84-6 |
---|
SMILES | [H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@]1(C[C@@H](COC(=O)C1=CC(Br)=CN=C1)CN2C)OC |
---|
InChI Identifier | InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1 |
---|
InChI Key | YSEXMKHXIOCEJA-FVFQAYNVSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as indoloquinolines. These are polycyclic aromatic compounds containing an indole fused to a quinoline. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Indoloquinolines |
---|
Direct Parent | Indoloquinolines |
---|
Alternative Parents | |
---|
Substituents | - Ergoline skeleton
- Indoloquinoline
- Benzoquinoline
- Pyrroloquinoline
- N-alkylindole
- 3-alkylindole
- Indole
- Indole or derivatives
- Isoindole or derivatives
- Pyridine carboxylic acid
- Alkaloid or derivatives
- Pyridine carboxylic acid or derivatives
- Aralkylamine
- Aryl bromide
- Aryl halide
- N-methylpyrrole
- Piperidine
- Benzenoid
- Pyridine
- Substituted pyrrole
- Pyrrole
- Heteroaromatic compound
- Tertiary amine
- Tertiary aliphatic amine
- Amino acid or derivatives
- Carboxylic acid ester
- Carboxylic acid derivative
- Azacycle
- Monocarboxylic acid or derivatives
- Dialkyl ether
- Ether
- Amine
- Organopnictogen compound
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organohalogen compound
- Organic nitrogen compound
- Organobromide
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.013 g/L | Not Available | LogP | 3.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Nicergoline GC-MS (Non-derivatized) - 70eV, Positive | splash10-01oy-0490000000-9946900f54448caef05c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nicergoline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nicergoline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 10V, Positive-QTOF | splash10-001i-0070900000-31a0fe890dfcef178a8d | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 20V, Positive-QTOF | splash10-001i-0090200000-e7257eb7542660c9b4c7 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 40V, Positive-QTOF | splash10-0pc0-2390000000-90dd1884dd9a2c36f452 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 10V, Negative-QTOF | splash10-001i-0110900000-1589cacb0deaf8363131 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 20V, Negative-QTOF | splash10-0532-0920500000-513d6a319962dbf7cbf3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 40V, Negative-QTOF | splash10-0a4j-0920000000-330babe951e9ccb2384a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 10V, Positive-QTOF | splash10-0udi-0000900000-2649cd14eb52b3a4655b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 20V, Positive-QTOF | splash10-001i-0000900000-a0efe44d5c8b6301ef53 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 40V, Positive-QTOF | splash10-0udi-0391000000-906dc143d70f8ce61d0e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 10V, Negative-QTOF | splash10-001i-0000900000-b7c2f66e57ef37412e1a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 20V, Negative-QTOF | splash10-003r-4100900000-fe5f17d8fb6e1a206cbd | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicergoline 40V, Negative-QTOF | splash10-0a6r-2900100000-a189dad93ea9944c264f | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00699 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00699 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00699 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 31373 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Nicergoline |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 34040 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Winblad B, Fioravanti M, Dolezal T, Logina I, Milanov IG, Popescu DC, Solomon A: Therapeutic use of nicergoline. Clin Drug Investig. 2008;28(9):533-52. [PubMed:18666801 ]
|
---|